4.7 Article

Emerging trends in metalloprotein inhibition

Journal

DALTON TRANSACTIONS
Volume 40, Issue 14, Pages 3445-3454

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c0dt01743d

Keywords

-

Funding

  1. University of California, San Diego
  2. National Institutes of Health [R01 HL00049, R21 HL094571]
  3. American Heart Association [0970028 N]
  4. Center for AIDS Research
  5. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094571] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098435] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Numerous metalloproteins are important therapeutic targets that are gaining increased attention in the medicinal and bioinorganic chemistry communities. This Perspective article describes some emerging trends and recent findings in the area of metalloprotein inhibitor discovery and development. In particular, increasing recognition of the importance of the metal-ligand interactions in these systems calls for more input and consideration from the bioinorganic community to address questions traditionally confined to the medicinal chemistry community.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available